Gainers
- Timber Pharmaceuticals TMBR shares rose 107.0% to $2.94 during Monday's pre-market session. The company's market cap stands at $8.9 million.
- China SXT Pharmaceuticals SXTC shares increased by 87.54% to $0.28. The company's market cap stands at $3.9 million.
- China Pharma Holding CPHI shares increased by 34.15% to $0.29. The market value of their outstanding shares is at $3.3 million.
- Strata Skin Sciences SSKN shares increased by 18.89% to $0.75. The company's market cap stands at $26.1 million.
- Anebulo Pharmaceuticals ANEB shares rose 16.78% to $3.27. The market value of their outstanding shares is at $83.8 million.
- NanoVibronix NAOV stock increased by 14.55% to $2.44. The market value of their outstanding shares is at $4.0 million.
Losers
- Assure Hldgs IONM stock declined by 13.2% to $0.36 during Monday's pre-market session. The company's market cap stands at $1.9 million.
- Connect Biopharma Hldgs CNTB shares decreased by 10.5% to $0.8. The market value of their outstanding shares is at $44.0 million.
- SHL Telemedicine SHLT stock fell 8.18% to $7.86.
- Alpha Tau Medical DRTS stock decreased by 8.11% to $3.4. The market value of their outstanding shares is at $235.5 million.
- OKYO Pharma OKYO shares fell 7.99% to $1.5. The market value of their outstanding shares is at $38.3 million. The company's, FY earnings came out 4 days ago.
- Predictive Oncology POAI stock fell 7.59% to $4.36. The company's market cap stands at $17.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CNTBConnect Biopharma Holdings Ltd
$0.98920.94%
CPHIChina Pharma Holding Inc
$0.179012.3%
DRTSAlpha Tau Medical Ltd
$3.10-0.80%
IONMAssure Holdings Corp
$1.863539.9%
NAOVNanoVibronix Inc
$0.5500-5.93%
OKYOOKYO Pharma Ltd
$1.09-%
POAIPredictive Oncology Inc
$0.6801-5.15%
SHLTSHL Telemedicine Ltd
$2.86-4.67%
SSKNStrata Skin Sciences Inc
$2.89-2.69%
SXTCChina SXT Pharmaceuticals Inc
$0.34932.71%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in